Literature DB >> 241025

Effect of bulbocapnine as a peripheral dopamine receptor antagonists in the anesthetized cat.

R G Pendleton, E Finlay, S Sherman.   

Abstract

We have found bulbocapnine to be an effective, apparently competitive inhibitor of dopamine depressor responses in the anesthetized, phenoxybenzamine-treated cat. The duration of action of the compound as a dopaminergic antagonist exceeded 3 hrs after an intravenous dose of 8 mg/kg. In the same preparation, however bulbocapnine did not at all inhibit the depressor responses to acetylcholine, histamine and isoproterenol, indicating a selectivity of action. Although administration of a high dose of propranolol (2 mg/kg, i.v.) did not alter the response of the alpha-receptor blocked cat to dopamine, the subsequent infusion of bulbocapnine remained effective. These results suggest that dopamine is acting as a blood pressure depressor agent via a unique receptor mechanism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 241025     DOI: 10.1007/bf00501304

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  7 in total

Review 1.  Neuroleptics as a guideline to biological research in psychotic disorders.

Authors:  H M van Praag
Journal:  Compr Psychiatry       Date:  1975 Jan-Feb       Impact factor: 3.735

2.  IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

Authors:  P A JANSSEN; C J NIEMEGEERS; K H SCHELLEKENS
Journal:  Arzneimittelforschung       Date:  1965-02

3.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

4.  Cardiovascular effects of dopamine in the anaesthetized dog.

Authors:  R G Sampson; G C Scroop; W J Louis
Journal:  Clin Exp Pharmacol Physiol       Date:  1974 Jan-Feb       Impact factor: 2.557

5.  Blockade of depressor response of dopamine.

Authors:  K M Dhasmana; K S Dixit; K N Dhawan; G P Gupta
Journal:  Jpn J Pharmacol       Date:  1969-03

6.  Cardiovascular effects of dopamine in the anesthetized cat.

Authors:  G Ross; A W Brown
Journal:  Am J Physiol       Date:  1967-04

7.  The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.

Authors:  P E Setler; R G Pendleton; E Finlay
Journal:  J Pharmacol Exp Ther       Date:  1975-03       Impact factor: 4.030

  7 in total
  2 in total

1.  Blood flow redistribution by dopamine in the feline gastrointestinal tract.

Authors:  R Kullmann; W R Breull; K Wassermann; A Konopatzki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

2.  Antagonism of the renal vasodilator activity of dopamine by metoclopramide.

Authors:  R A Hahn; J R Wardell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.